Clinical Trial Update: Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD) [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study of esomeprazole magnesium in children aged 1 to 11 years with endoscopically proven gastroesophageal reflux disease has been com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Esomeprazole magnesium (esomeprazole magnesium)

Snippet

Sponsor: AstraZeneca | Conditions: Endoscopically-Proven GERD, Reflux | Phase 1 | Status: COMPLETED